Crystal structure of 5-{4′-[(2-{2-[2-(2-ammonio­eth­oxy)eth­oxy]eth­oxy}eth­yl)carbamo­yl]-4-meth­oxy-[1,1′-biphen­yl]-3-yl}-3-oxo-1,2,5-thia­diazo­lidin-2-ide 1,1-dioxide: a potential inhibitor of the enzyme protein tyrosine phosphatase 1B (PTP1B)

Ruddraraju, K.V.; Hillebrand, R.; Barnes, C.L.; Gates, K.S.

doi:10.1107/S2056989015003850

Acta Crystallographica Section E
Acta Crystallographica
Section E CRYSTALLOGRAPHIC COMMUNICATIONS

IUCr IT WDC

home archive editors for authors for readers submit open access

view article

Figure 3
A view along the c axis of the crystal packing of the title compound. The N—H⋯O and N—H⋯O hydrogen bonds are shown as dashed lines (see Table 1

for details) and C-bound H atoms have been omitted for clarity.

CRYSTALLOGRAPHIC
COMMUNICATIONS

ISSN: 2056-9890

Volume 71| Part 4| April 2015| Pages 336-338

doi:10.1107/S2056989015003850

Open

access

Follow Acta Cryst. E

Search IUCr Journals		doi		Advanced search
Author		volume	page